Affymax, Inc. (Nasdaq:AFFY) today announced the Company™s participation at the following investor conferences in August.

Arlene Morris, president and chief executive officer, will present at BMO Capital Markets Focus on Healthcare 2008 Investor Conference
Millennium Broadway Hotel, New York City
Tuesday, August 5
3:30 p.m. ET
Chris Dammann, vice president of Business Development, will present at Bank of America 2008 Specialty Pharmaceuticals Conference
Southampton Inn, Long Island, NY
Thursday, August 7, 2008
10:15 a.m. ET

A live webcast of the presentation will be available on the investors section of the company™s website at A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax™s lead product candidate, Hematide„, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure and in a Phase 1 clinical trial for the treatment of anemia in cancer patients. For additional information, please visit

Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications